Principal Financial Group Inc Sarepta Therapeutics, Inc. Transaction History
Principal Financial Group Inc
- $167 Billion
- Q1 2025
A detailed history of Principal Financial Group Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 244,766 shares of SRPT stock, worth $3.39 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
244,766
Previous 282,084
13.23%
Holding current value
$3.39 Million
Previous $34.3 Million
54.46%
% of portfolio
0.01%
Previous 0.02%
Shares
31 transactions
Others Institutions Holding SRPT
# of Institutions
491Shares Held
89.6MCall Options Held
1.39MPut Options Held
1.11M-
Black Rock Inc. New York, NY10.3MShares$143 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$126 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$125 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$56.4 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$46.6 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.21B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...